Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 34.

Ishida, Yoshihiro; Otsuka, Atsushi; Tanaka, Hidenori; Levesque, Mitchell P; Dummer, Reinhard; Kabashima, Kenji (2017). HLA-A*26 Is Correlated With Response to Nivolumab in Japanese Melanoma Patients. Journal of Investigative Dermatology, 137(11):2443-2444.

Xue, Gongda; Kohler, Reto; Tang, Fengyuan; Hynx, Debby; Wang, Yuhua; Orso, Francesca; Prêtre, Vincent; Ritschard, Reto; Hirschmann, Petra; Cron, Peter; Roloff, Tim; Dummer, Reinhard; Mandalà, Mario; Bichet, Sandrine; Genoud, Christel; Meyer, Alexandra G; Muraro, Manuele G; Spagnoli, Giulio C; Taverna, Daniela; Rüegg, Curzio; Merghoub, Taha; Massi, Daniela; Tang, Huifang; Levesque, Mitchell P; Dirnhofer, Stephan; Zippelius, Alfred; Hemmings, Brian A; Wicki, Andreas (2017). mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition. OncoTarget, 8(41):69204-69218.

Dummer, Reinhard; Ramelyte, Egle; Schindler, Sabrina; Thürigen, Olaf; Levesque, Mitchell P; Koelblinger, Peter (2017). MEK inhibition and immune responses in advanced melanoma. OncoImmunology, 6(8):e1335843.

Mangana, Joanna; Cheng, Phil F; Kaufmann, Corina; Amann, Valerie C; Frauchiger, Anna L; Stögner, Viola; Held, Ulrike; von Moos, Roger; Michielin, Olivier; Braun, Ralph P; Levesque, Mitchell P; Goldinger, Simone M; Dummer, Reinhard (2017). Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland. Melanoma research, 27(4):358-368.

Smith, Michael P; Rowling, Emily J; Miskolczi, Zsofia; Ferguson, Jennifer; Spoerri, Loredana; Haass, Nikolas K; Sloss, Olivia; McEntegart, Sophie; Arozarena, Imanol; von Kriegsheim, Alex; Rodriguez, Javier; Brunton, Holly; Kmarashev, Jivko; Levesque, Mitchell P; Dummer, Reinhard; Frederick, Dennie T; Andrews, Miles C; Cooper, Zachary A; Flaherty, Keith T; Wargo, Jennifer A; Wellbrock, Claudia (2017). Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure. EMBO Molecular Medicine, 9(8):1011-1029.

Nowicka, Malgorzata; Krieg, Carsten; Weber, Lukas M; Hartmann, Felix J; Guglietta, Silvia; Becher, Burkhard; Levesque, Mitchell P; Robinson, Mark D (2017). CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets. F1000Research, 6:748.

Haueis, Silvia A; Kränzlin, Pascale; Mangana, Joanna; Cheng, Phil F; Urosevic-Maiwald, Mirjana; Braun, Ralph P; Levesque, Mitchell P; Dummer, Reinhard; Goldinger, Simone M (2017). Does the distribution pattern of brain metastases during BRAF inhibitor therapy reflect phenotype switching? Melanoma research, 27(3):231-237.

Levesque, Mitchell P; Cheng, Phil F; Raaijmakers, Marieke I G; Saltari, Annalisa; Dummer, Reinhard (2017). Metastatic melanoma moves on: translational science in the era of personalized medicine. Cancer Metastasis Reviews, 36(1):7-21.

Farsam, Vida; Basu, Abhijit; Gatzka, Martina; Treiber, Nicolai; Schneider, Lars A; Mulaw, Medhanie A; Lucas, Tanja; Kochanek, Stefan; Dummer, Reinhard; Levesque, Mitchell P; Wlaschek, Meinhard; Scharffetter-Kochanek, Karin (2016). Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration. OncoTarget, 7(50):83554-83569.

Raaijmakers, Marieke I G; Widmer, Daniel S; Narechania, Apurva; Eichhoff, Ossia; Freiberger, Sandra N; Wenzina, Judith; Cheng, Phil F; Mihic-Probst, Daniela; Desalle, Rob; Dummer, Reinhard; Levesque, Mitchell P (2016). Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance. OncoTarget, 7(47):77163-77174.

Huber, Roman; Meier, Barbara; Otsuka, Atsushi; Fenini, Gabriele; Satoh, Takashi; Gehrke, Samuel; Widmer, Daniel; Levesque, Mitchell P; Mangana, Joanna; Kerl, Katrin; Gebhardt, Christoffer; Fujii, Hiroko; Nakashima, Chisa; Nonomura, Yumi; Kabashima, Kenji; Dummer, Reinhard; Contassot, Emmanuel; French, Lars E (2016). Tumour hypoxia promotes melanoma growth and metastasis via High Mobility Group Box-1 and M2-like macrophages. Scientific Reports, 6:29914.

Claps, Giuseppina; Cheli, Yann; Zhang, Tongwu; Scortegagna, Marzia; Lau, Eric; Kim, Hyungsoo; Qi, Jianfei; Li, Jian-Liang; James, Brian; Dzung, Andreas; Levesque, Mitchell P; Dummer, Reinhard; Hayward, Nicholas K; Bosenberg, Marcus; Brown, Kevin M; Ronai, Ze'ev A (2016). A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis. Cell Reports, 15(9):1884-1892.

Smith, Michael P; Brunton, Holly; Rowling, Emily J; Ferguson, Jennifer; Arozarena, Imanol; Miskolczi, Zsofia; Lee, Jessica L; Girotti, Maria R; Marais, Richard; Levesque, Mitchell P; Dummer, Reinhard; Frederick, Dennie T; Flaherty, Keith T; Cooper, Zachary A; Wargo, Jennifer A; Wellbrock, Claudia (2016). Inhibiting drivers of non-mutational drug tolerance is a salvage strategy for targeted melanoma therapy. Cancer Cell, 29(3):270-84.

Levesque, Mitchell P; Dummer, Reinhard; Beerenwinkel, Niko (2015). Perturbing resistance: a network perspective. Pigment Cell & Melanoma Research, 29(1):5-7.

Freiberger, Sandra N; Cheng, Phil F; Iotzova-Weiss, Guergana; Neu, Johannes; Liu, Qinxiu; Dziunycz, Piotr; Zibert, John R; Dummer, Reinhard; Skak, Kresten; Levesque, Mitchell P; Hofbauer, Günther F L (2015). Ingenol mebutate signals via PKC/MEK/ERK in keratinocytes and induces interleukin decoy receptors IL1R2 and IL13RA2. Molecular Cancer Therapeutics, 14(9):2132-2142.

Widmer, Daniel S; Eichhoff, Ossia M; Dummer, Reinhard; Levesque, Mitchell P (2015). Melanoma's next top model, it is in the air. Experimental Dermatology, 24(9):659-660.

Kim, Hyungsoo; Frederick, Dennie T; Levesque, Mitchell P; Cooper, Zachary A; Feng, Yongmei; Krepler, Clemens; Brill, Laurence; Samuels, Yardena; Hayward, Nicholas K; Perlina, Ally; Piris, Adriano; Zhang, Tongwu; Halaban, Ruth; Herlyn, Meenhard M; Brown, Kevin M; Wargo, Jennifer A; Dummer, Reinhard; Flaherty, Keith T; Ronai, Ze'ev A (2015). Downregulation of the ubiquitin ligase RNF125 underlies resistance of melanoma cells to BRAF inhibitors via JAK1 deregulation. Cell Reports, 11(9):1458-1473.

Otsuka, Atsushi; Levesque, Mitchell P; Dummer, Reinhard; Kabashima, Kenji (2015). Hedgehog signaling in basal cell carcinoma. Journal of Dermatological Science, 78(2):95-100.

Raaijmakers, Marieke I G; Widmer, Daniel S; Maudrich, Melanie; Koch, Tabea; Langer, Alice; Flace, Anna; Schnyder, Claudia; Dummer, Reinhard; Levesque, Mitchell P (2015). A new live cell biobank workflow efficiently recovers heterogeneous melanoma cells from native biopsies. Experimental Dermatology, 24(5):377-380.

Dummer, Reinhard; Goldinger, Simone M; Paulitschke, Verena; Levesque, Mitchell P (2015). Curing advanced melanoma by 2025. Current Opinion in Oncology, 27(2):125-127.

Guenova, Emmanuella; Skabytska, Yuliya; Hoetzenecker, Wolfram; Weindl, Günther; Sauer, Karin; Tham, Manuela; Kim, Kyu-Won; Park, Ji-Hyeon; Seo, Ji Hae; Ignatova, Desislava; Cozzio, Antonio; Levesque, Mitchell P; Volz, Thomas; Köberle, Martin; Kaesler, Susanne; Thomas, Peter; Mailhammer, Reinhard; Ghoreschi, Kamran; Schäkel, Knut; Amarov, Boyko; Eichner, Martin; Schaller, Martin; Clark, Rachael A; Röcken, Martin; Biedermann, Tilo (2015). IL-4 abrogates T(H)17 cell-mediated inflammation by selective silencing of IL-23 in antigen-presenting cells. Proceedings of the National Academy of Sciences of the United States of America, 112(7):2163-2168.

Shakhova, Olga; Cheng, Phil; Mishra, Pravin J; Zingg, Daniel; Schaefer, Simon M; Debbache, Julien; Häusel, Jessica; Matter, Claudia; Guo, Theresa; Davis, Sean; Meltzer, Paul; Mihic-Probst, Daniela; Moch, Holger; Wegner, Michael; Merlino, Glenn; Levesque, Mitchell P; Dummer, Reinhard; Santoro, Raffaella; Cinelli, Paolo; Sommer, Lukas (2015). Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma. PLoS Genetics, 11(1):e1004877.

Zingg, Daniel; Debbache, Julien; Schaefer, Simon M; Tuncer, Eylul; Frommel, Sandra C; Cheng, Phil; Arenas-Ramirez, Natalia; Haeusel, Jessica; Zhang, Yudong; Bonalli, Mario; McCabe, Michael T; Creasy, Caretha L; Levesque, Mitchell P; Boyman, Onur; Santoro, Raffaella; Shakhova, Olga; Dummer, Reinhard; Sommer, Lukas (2015). The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors. Nature Communications, 6:6051.

Otsuka, Atsushi; Dreier, Jil; Cheng, Phil F; Nägeli, Mirjam; Lehmann, Holger; Felderer, Lea; Frew, Ian J; Matsushita, Shigeto; Levesque, Mitchell P; Dummer, Reinhard (2015). Hedgehog Pathway Inhibitors Promote Adaptive Immune Responses in Basal Cell Carcinoma. Clinical Cancer Research:1289-1297.

Cheng, Phil F; Dummer, Reinhard; Levesque, Mitchell P (2015). Data mining the cancer genome atlas in the era of precision cancer medicine. Swiss Medical Weekly, 145:w14183.

Cheng, Phil F; Shakhova, Olga; Widmer, Daniel S; Eichhoff, Ossia M; Zingg, Daniel; Frommel, Sandra C; Belloni, Benedetta; Raaijmakers, Marieke Ig; Goldinger, Simone M; Santoro, Raffaella; Hemmi, Silvio; Sommer, Lukas; Dummer, Reinhard; Levesque, Mitchell P (2015). Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma. Genome Biology, 16:42.

Dummer, Reinhard; Goldinger, Simone M; Widmer, Daniel; Dreier, Jil; Levesque, Mitchell P (2014). To B-(RAF) or not to be. Journal of Investigative Dermatology, 134(5):1200-1201.

Barysch, Marjam J; Levesque, Mitchell P; Cheng, Phil; Karpova, Maria B; Mihic-Probst, Daniela; Civenni, Gianluca; Shakhova, Olga; Sommer, Lukas; Biedermann, Thomas; Schiestl, Clemens; Dummer, Reinhard (2014). Coexpression of SOX10/CD271 (p75(NTR)) and β-Galactosidase in large to giant congenital melanocytic nevi of pediatric patients. Dermatopathology, 1(1):35-46.

Barysch, Marjam J; Levesque, Mitchell P; Cheng, Phil; Karpova, Maria B; Mihic-Probst, Daniela; Civenni, Gianluca; Shakhova, Olga; Sommer, Lukas; Biedermann, Thomas; Schiestl, Clemens; Dummer, Reinhard (2014). Coexpression of SOX10/CD271 (p75NTR) and beta-galactosidase in large to giant congenital melanocytic nevi of pediatric patients. Dermatopathology, 1(1):35-46.

Guenova, Emmanuella; Hoetzenecker, Wolfram; Rozati, Sima; Levesque, Mitchell P; Dummer, Reinhard; Cozzio, Antonio (2014). Novel therapies for cutaneous T-cell lymphoma: what does the future hold? Expert Opinion on Investigational Drugs, 23(4):457-467.

Widmer, Daniel S; Hoek, Keith S; Cheng, Phil F; Eichhoff, Ossia M; Biedermann, Thomas; Raaijmakers, Marieke I G; Hemmi, Silvio; Dummer, Reinhard; Levesque, Mitchell P (2013). Hypoxia contributes to melanoma heterogeneity by triggering HIF1α-dependent phenotype switching. Journal of Investigative Dermatology, 133(10):2436-2443.

Raaijmakers, Marieke I G; Rozati, Sima; Goldinger, Simone M; Widmer, Daniel S; Dummer, Reinhard; Levesque, Mitchell P (2013). Melanoma immunotherapy: historical precedents, recent successes and future prospects. Immunotherapy, 5(2):169-182.

Das Thakur, Meghna; Salangsang, Fernando; Landman, Allison S; Sellers, William R; Pryer, Nancy K; Levesque, Mitchell P; Dummer, Reinhard; McMahon, Martin; Stuart, Darrin D (2013). Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance. Nature, 494(7436):251-255.

Rozati, Sima; Naef, Lukas; Levesque, Mitchell P; French, Lars E; Dummer, Reinhard (2013). Real-life experience with pegylated interferon and conventional interferon in adjuvant melanoma therapy. Journal of Immunotherapy, 36(1):52-56.

This list was generated on Sun Nov 19 08:18:50 2017 CET.